Ateme Stock
A very strong showing by Ateme today, with an increase of €0.80 (5.190%) compared to yesterday's price.
The community is currently still undecided about Ateme with 1 Buy predictions and 0 Sell predictions.
However, we have a potential of -1.356% for Ateme as the target price of €16.00 is below the current price of €16.22.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Ateme stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Ateme in the next few years
Pros
1
Could be worthwhile Investment >10% per year
Cons
0
-
Performance of Ateme vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ateme | 5.190% | 5.462% | 6.570% | 37.691% | -1.816% | - | - |
| Ekinops Sas | 1.040% | 0.000% | 3.670% | 19.366% | 1.043% | - | - |
| Parrot S.A. | -1.960% | -3.710% | -10.802% | 140.088% | 7.708% | 2.251% | -66.789% |
| Comtech Telecommunications Corp. | 1.040% | -3.465% | -9.722% | 21.875% | 18.182% | -22.619% | -2.563% |
Other discussions about Ateme Stock
New thread ForumNews
ATEME : FIRST QUARTER 2021 REVENUES
Paris, 6 May 2021 – 17:45 pm
- Revenues of €15.5 million up 26% year-on-year and by 8% on a like-for-like basis
- Leveraging the combination of Ateme and Anevia technologies to address new market
ATEME : FULL YEAR 2020 RESULTS
Paris, 25 March 2021 – 17:45 pm
- GROSS MARGIN of €38.9 MILLION, UP 8%
- OPERATING PROFIT of €1.9 MILLION
- smooth intergation of anevia virtually complete
- new LONG-TERM ebitda target of €30M in
ATEME : ?NUMBER OF SHARES AND VOTING RIGHTS AS OF JANUARY 31, 2021
Paris, February 8, 2021 – 18.00 CET
NUMBER OF SHARES AND VOTING RIGHTS
(Article L.233-8-II of Commercial Law)
ATEME shares (ISIN Code: FR0011992700 – Ticker: ATEME) are listed for trading on
